Top 5 Takeaways Extensive Surveillance: The New Vaccine Surveillance Network (NVSN) conducted comprehensive surveillance of acute respiratory illnesses (ARIs) in children across the U.S. from 2016 to 2021. Major Viruses
Tag: Infectious Disease
Top 5 Takeaways Significant Underutilization of Antivirals: Review of 110 immunosuppressed Veterans Health Administration patients with nonsevere COVID-19 showed 80% were not offered antiviral drugs, primarily due to mild symptoms.
Top 5 Takeaways First Reported U.S. Case of Monkeypox from Needlestick in Healthcare: A nurse in Florida contracted monkeypox from a needlestick injury while collecting a swab from a patient’s
Top 5 Takeaways Effectiveness of Monovalent mRNA Vaccines: During the SARS-CoV-2 Omicron BA.1/BA.2 and BA.4/BA.5 periods, the effectiveness of three-dose monovalent mRNA vaccines against COVID-19–associated hospitalization waned over time. Vaccine
Top 5 Takeaways Vaccine Effectiveness (VE): Among immunocompromised adults, the VE of 2-dose monovalent mRNA COVID-19 vaccines against hospitalization during Omicron predominance was 36%. VE increased to 67% after a
Top 5 Takeaways This report details five cases of ocular monkeypox in the U.S. from July to September 2022, highlighting serious complications including vision impairment and prolonged illness. Patients with
Top 5 Takeaways Oral Antivirals for COVID-19: The study analyzes the dispensing of oral antiviral drugs, Paxlovid and Lagevrio, for COVID-19 treatment, focusing on zip code-level social vulnerability in the
Top 5 Takeaways Outbreak Identification and Response: In March 2023, Maine CDC investigated a Pseudomonas aeruginosa outbreak at a hotel pool. Among 35 guests surveyed, 23 developed symptoms like ear
Top 5 Takeaways Effective Detection of Mpox in Wastewater: The study revealed a sensitivity of 32% in detecting a single mpox case in large population samples through wastewater surveillance. Sensitivity
Top 5 Takeaways JYNNEOS Vaccine Distribution: Over 931,000 JYNNEOS vaccine doses were administered in the U.S. from May 22 to October 10, 2022, as part of the monkeypox outbreak response.